In 40 pate in ts with metas t atic brain t umor and acute Iy mphoblastic leukemia received whole brain irradiatio n, the dose de livered to the eyelens was measured using T. L. D. ch ips a pp lied on the eyes as usual shield.The dose to the eye le ns was expressed t he re lati ve dose to the mid brain dose. Radiotherapy was adm inistered using Co.60 teletherapy with bilateral who le brain irrad iation .The resul ts are as fo llows:1. The dose to t he ri ght eye f rom its in c ipi ent fie ld is 16.6% of tumor dose wh il e the dose to the same eye from the opposite fie ld is 4 1. 2 %. On left eye , 19.2% from incipie nt field wh il e 39.2% from the opposite fie ld .2. Tota l rece ived dose to ri ght an d left eyes is 28.9%, 29.8 % of tumor dose respectively.3. Comparing len s shield group w ith o rb it shield group received dose is 22.5 %, 15.8% of tumor dose, respectivel y.4. The dose deli vered to the eye lens in ipsilateral side depends upon inter nal scatte rin g, locatio n of lead shield and penetrat ing dose of lead in itsel f. The dose in co n tralatera l side depends upon divergency of radiation beam and patient's ma lpos ition.5. The dose to the eye len s should be less than 10 % of tumor dose with adequate shield , also not m iss ing t he chance of leptome ninge a l recurrence because of overshi e lding.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.